Also, 66% of patients report a reduction in skin pain and itching. A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor receptor ...

Whether or not new topical agents are likely to be developed, combinations may be a viable future option for effective treatment, although regulatory hurdles make this option very difficult both ...

Many of us have likely heard of or used erythromycin. It's a widely-used antibiotic for treating various bacterial infections, including respiratory, skin, and some sexually transmitted infections. It ...